Study for Patients With Non Small Cell Lung Cancer (NSCLC)

• Status: Unknown status
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized study to assess the efficacy and safety of chemotherapy with platin compared to chemotherapy without platin.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Charite University, Berlin, Germany
• Collaborators: Bristol-Myers Squibb; Pierre Fabre Pharma GmbH
• Treatments: Albumin-Bound Paclitaxel; Carboplatin; Paclitaxel; Vinorelbine

Criteria

Inclusion Criteria:

• Chemotherapy naive patients with histologically confirmed NSCLC stage III and IV

Exclusion Criteria:

• New York Heart Association (NYHA) III or IV

• Brain metastases

• Neurotoxicity Grade 2 or greater